1.A study on hepatitis C virus antibody (anti-HCV) in healthy blooddonors and patients with type B and NANB hepatitia and chronicliver disease.
Jeong Nyeo LEE ; Eun Joo HWANG ; Jong Rae JO ; Kun Ju HAHM ; Eun Yup LEE ; Han Chul SON ; Soon Ho KIM
Korean Journal of Clinical Pathology 1991;11(1):207-214
No abstract available.
Hepacivirus*
;
Hepatitis C*
;
Hepatitis*
;
Humans
2.Acute Marchiafava-Bignami Disease With Typical White Matter Involvement on Diffusion Weighted MRI.
Hey Eun SHIN ; Jae Guk KIM ; Seong Rae JO ; Seong Hae JEONG ; Soo Jin YOON
Journal of the Korean Neurological Association 2008;26(4):376-378
Marchiafava-Bignami disease (MBD) is characterized by cerebral white matter lesions associated with chronic alcoholism. Premortem diagnosis of MBD is usually based on history and clinical manifestations. We report a case of acute MBD in which diffusion-weighted MRI (DWI) showed high signal intensities along the white matter including the corpus callosum. DWI may be useful in premortem diagnosis of acute MBD.
Alcoholism
;
Corpus Callosum
;
Diffusion
;
Diffusion Magnetic Resonance Imaging
;
Humans
;
Leukoencephalopathies
;
Marchiafava-Bignami Disease
3.Clinical survey of 8 cases of endodermal sinus tumor.
Kwang Soon AHN ; Rae Ok PARK ; Jung Il CHA ; Byung Hun JUNG ; Jin Woo KIM ; Se Il KIM ; Sung Eun NAMKOONG ; Seung Jo KIM
Korean Journal of Obstetrics and Gynecology 1992;35(1):68-76
No abstract available.
Endoderm*
;
Endodermal Sinus Tumor*
4.Lesson from COVID-19 outbreak; importance of standard precautions to febrile neutropenia prevention in patients with breast cancer who received adjuvant chemotherapy:a retrospective observational study
Ji Eun PARK ; Jieun YANG ; Sanghoon HAN ; Jeong Rae YOO ; Misun KIM ; Donghyoun LEE ; Jaemin JO
Annals of Surgical Treatment and Research 2024;107(4):195-202
Purpose:
Intensive cytotoxic chemotherapy increases the risk of infection in patients with cancer by inducing bone marrow suppression and mucosal injury. Febrile neutropenia (FN) is the most important clinical adverse event in patients with cancer receiving cytotoxic chemotherapy. To prevent FN, standard precautions including hand and respiratory hygiene are generally recommended, but the exact effect of non-pharmacologic intervention has not been clearly proven in the clinical setting. We aimed to compare the incidence of FN between the pre-coronavirus disease 19 (COVID-19) era vs. the postCOVID-19 era.
Methods:
We retrospectively enrolled patients with breast cancer who received an adriamycin and cyclophosphamide (AC) regimen containing adjuvant chemotherapy at Jeju National University Hospital. We compared the incidence of FN between the pre- and post-COVID-19 period and analyzed characteristics of the event and other clinical risk factors.
Results:
In total, 149 patients were enrolled, including 94 who received AC chemotherapy in the pre-COVID-19 era and 55 who received it in the post-COVID-19 era. Sixteen patients (10.7%) experienced FN. Fourteen (14.9%) and 2 events (3.6%) occurred in pre-COVID-19 and post-COVID-19 eras, respectively. The post-COVID-19 era was the only risk factor for FN (P = 0.032).
Conclusion
We found an association between FN occurrence and the COVID-19 outbreak, providing indirect evidence of the importance of non-pharmacological measures to reduce FN risk in patients with breast cancer. Further research is required to confirm the standard precautions for FN prevention in patients with cancer.
5.Lesson from COVID-19 outbreak; importance of standard precautions to febrile neutropenia prevention in patients with breast cancer who received adjuvant chemotherapy:a retrospective observational study
Ji Eun PARK ; Jieun YANG ; Sanghoon HAN ; Jeong Rae YOO ; Misun KIM ; Donghyoun LEE ; Jaemin JO
Annals of Surgical Treatment and Research 2024;107(4):195-202
Purpose:
Intensive cytotoxic chemotherapy increases the risk of infection in patients with cancer by inducing bone marrow suppression and mucosal injury. Febrile neutropenia (FN) is the most important clinical adverse event in patients with cancer receiving cytotoxic chemotherapy. To prevent FN, standard precautions including hand and respiratory hygiene are generally recommended, but the exact effect of non-pharmacologic intervention has not been clearly proven in the clinical setting. We aimed to compare the incidence of FN between the pre-coronavirus disease 19 (COVID-19) era vs. the postCOVID-19 era.
Methods:
We retrospectively enrolled patients with breast cancer who received an adriamycin and cyclophosphamide (AC) regimen containing adjuvant chemotherapy at Jeju National University Hospital. We compared the incidence of FN between the pre- and post-COVID-19 period and analyzed characteristics of the event and other clinical risk factors.
Results:
In total, 149 patients were enrolled, including 94 who received AC chemotherapy in the pre-COVID-19 era and 55 who received it in the post-COVID-19 era. Sixteen patients (10.7%) experienced FN. Fourteen (14.9%) and 2 events (3.6%) occurred in pre-COVID-19 and post-COVID-19 eras, respectively. The post-COVID-19 era was the only risk factor for FN (P = 0.032).
Conclusion
We found an association between FN occurrence and the COVID-19 outbreak, providing indirect evidence of the importance of non-pharmacological measures to reduce FN risk in patients with breast cancer. Further research is required to confirm the standard precautions for FN prevention in patients with cancer.
6.Lesson from COVID-19 outbreak; importance of standard precautions to febrile neutropenia prevention in patients with breast cancer who received adjuvant chemotherapy:a retrospective observational study
Ji Eun PARK ; Jieun YANG ; Sanghoon HAN ; Jeong Rae YOO ; Misun KIM ; Donghyoun LEE ; Jaemin JO
Annals of Surgical Treatment and Research 2024;107(4):195-202
Purpose:
Intensive cytotoxic chemotherapy increases the risk of infection in patients with cancer by inducing bone marrow suppression and mucosal injury. Febrile neutropenia (FN) is the most important clinical adverse event in patients with cancer receiving cytotoxic chemotherapy. To prevent FN, standard precautions including hand and respiratory hygiene are generally recommended, but the exact effect of non-pharmacologic intervention has not been clearly proven in the clinical setting. We aimed to compare the incidence of FN between the pre-coronavirus disease 19 (COVID-19) era vs. the postCOVID-19 era.
Methods:
We retrospectively enrolled patients with breast cancer who received an adriamycin and cyclophosphamide (AC) regimen containing adjuvant chemotherapy at Jeju National University Hospital. We compared the incidence of FN between the pre- and post-COVID-19 period and analyzed characteristics of the event and other clinical risk factors.
Results:
In total, 149 patients were enrolled, including 94 who received AC chemotherapy in the pre-COVID-19 era and 55 who received it in the post-COVID-19 era. Sixteen patients (10.7%) experienced FN. Fourteen (14.9%) and 2 events (3.6%) occurred in pre-COVID-19 and post-COVID-19 eras, respectively. The post-COVID-19 era was the only risk factor for FN (P = 0.032).
Conclusion
We found an association between FN occurrence and the COVID-19 outbreak, providing indirect evidence of the importance of non-pharmacological measures to reduce FN risk in patients with breast cancer. Further research is required to confirm the standard precautions for FN prevention in patients with cancer.
7.Lesson from COVID-19 outbreak; importance of standard precautions to febrile neutropenia prevention in patients with breast cancer who received adjuvant chemotherapy:a retrospective observational study
Ji Eun PARK ; Jieun YANG ; Sanghoon HAN ; Jeong Rae YOO ; Misun KIM ; Donghyoun LEE ; Jaemin JO
Annals of Surgical Treatment and Research 2024;107(4):195-202
Purpose:
Intensive cytotoxic chemotherapy increases the risk of infection in patients with cancer by inducing bone marrow suppression and mucosal injury. Febrile neutropenia (FN) is the most important clinical adverse event in patients with cancer receiving cytotoxic chemotherapy. To prevent FN, standard precautions including hand and respiratory hygiene are generally recommended, but the exact effect of non-pharmacologic intervention has not been clearly proven in the clinical setting. We aimed to compare the incidence of FN between the pre-coronavirus disease 19 (COVID-19) era vs. the postCOVID-19 era.
Methods:
We retrospectively enrolled patients with breast cancer who received an adriamycin and cyclophosphamide (AC) regimen containing adjuvant chemotherapy at Jeju National University Hospital. We compared the incidence of FN between the pre- and post-COVID-19 period and analyzed characteristics of the event and other clinical risk factors.
Results:
In total, 149 patients were enrolled, including 94 who received AC chemotherapy in the pre-COVID-19 era and 55 who received it in the post-COVID-19 era. Sixteen patients (10.7%) experienced FN. Fourteen (14.9%) and 2 events (3.6%) occurred in pre-COVID-19 and post-COVID-19 eras, respectively. The post-COVID-19 era was the only risk factor for FN (P = 0.032).
Conclusion
We found an association between FN occurrence and the COVID-19 outbreak, providing indirect evidence of the importance of non-pharmacological measures to reduce FN risk in patients with breast cancer. Further research is required to confirm the standard precautions for FN prevention in patients with cancer.
8.A Case of Lipoid Pneumonia after Ingestion of Green Perilla Oil.
Kwang Jin JEONG ; Yong Eun KIM ; Gueon Jo LIM ; Kyong Duk SUH ; Jin Do KIM ; Ju Hong LEE ; Dae Young KOO ; IL Sun LEE
Tuberculosis and Respiratory Diseases 1999;47(1):123-126
We report a case of lipoid pneumo nia in a 57-year-old man who had a history of ingestion of green perilla oil and residual neurologic deficit of cerebral infarction with right hemiparesis. Lipoid pneumonia was diagnosed by bronchoalveolar lavage.
Bronchoalveolar Lavage
;
Cerebral Infarction
;
Eating*
;
Humans
;
Middle Aged
;
Neurologic Manifestations
;
Paresis
;
Perilla*
;
Pneumonia*
9.The Significance of Mucosal Biopsy in Normal Colonoscopy.
Jae Seon KIM ; Eun Rae JO ; So Young KWON ; Kwan Soo BYUN ; Young Tae BAK ; Jin Ho KIM ; Jong Guk KIM ; Chang Hong LEE ; Chul Hwan KIM ; Nam Hee WON
Korean Journal of Gastrointestinal Endoscopy 1993;13(4):713-718
Many patients of gastroenterology clinics complain symptoms requiring colonic investigations. Radiological examinations may fail to detect early inflammatory bowel diseases and small neoplasms or polyps. And therefore colonoscopies are performed in preference to barium enema. Recently several reports raised a question regarding whether biopsy is necessary in a macroscopically normal colon. To determine what proportion of apparently normal colons is histologically abnormal, to measure the thickness of subepithelial basement membrane(SEBM) in normal colons, and to see whether the thiekness varies according to the different areas of the large bowel we prospectively analyzed 100 consecutive subjects with normal laboratory findings and normal mucosa on colonoscopy. Significant histologic abnormalities were not detected in all 100 cases. Thickness of SEBM (mean+SD) was 1.6+0.4 um at hepatic flexure, 1.6+0.4um at splenic flexure and 1.7+0.4 pm at sigmoid colon. The SEBM was significantly thicker at the sigmoid colon than at the hepatic flexure. Range of thickness of normal SEBM was 0.8 to 2.5 pm(mean+2SD). Maximum thickness of SEBM was 3 pm. The result of this study suggests that doing colonoscopic biopsies in all normal colons do not seem to be essential in Koreans yet.
Barium
;
Biopsy*
;
Colon
;
Colon, Sigmoid
;
Colon, Transverse
;
Colonoscopy*
;
Enema
;
Gastroenterology
;
Humans
;
Inflammatory Bowel Diseases
;
Mucous Membrane
;
Polyps
;
Prospective Studies
10.A case of Thrombotic thrombocytopenic purpura - hemolytic uremic syndrome presenting with cortical blindness confirmed by MRI.
Gueon Jo LIM ; Yong Eun KIM ; Kyong Duk SUH ; Yu Seong JEONG ; Jin Do KIM ; Ju Hong LEE ; Dae Young KOO ; Tae Yoon LEE ; Yong Hun SIN ; Yong Ki PARK
Korean Journal of Medicine 1999;56(1):119-123
Thrombotic thrombocytopenic purpura (TTP) and the related hemolytic uremic syndrome (HUS) are disorders characterized by thrombocytopenia, microangiopathic hemolytic anemia, a variable degree of impairment of renal function and fluctuating neurological symptoms, which are thought to be due to platelet activation and subsequent formation of thrombi in the microcirculation. The fact that there was no clear-cut clinical and laboratory features that differentiate HUS from TTP has lead to view these two syndromes as a clinical continuum. Microvascular thrombosis is the typical lesion and closely related with endothelial injury and platelet activation. Pathologic alterations of the brain parenchyma are mainly manifested by small multiple infarcts. Numerous cases of CNS complications of these syndromes have been evaluated by using CT, but few reports have mentioned the MR findings. We experienced a case of TTP-HUS that had clinical features of cortical blindness and the brain lesion was confirmed by MRI showing cerebral infarct at the occipital area but it was reversible course. So we report this case with a brief review of literature.
Anemia, Hemolytic
;
Blindness, Cortical*
;
Brain
;
Hemolytic-Uremic Syndrome*
;
Magnetic Resonance Imaging*
;
Microcirculation
;
Platelet Activation
;
Purpura, Thrombotic Thrombocytopenic*
;
Thrombocytopenia
;
Thrombosis